Further proof of a paradoxical relationship between high-density lipoprotein levels and adverse cardiovascular outcomes: are there implications for cardiovascular disease prevention?

被引：4
|
作者：
Kunutsor, Setor K. [1 ]
Laukkanen, Jari A. [2 ,3 ,4 ]
机构：
[1] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Gwendolen Rd, Leicester LE5 4WP, England
[2] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Yliopistonranta 1C, Canthia Bldg, B wing, FI-70211 Kuopio, Finland
[3] Univ Eastern Finland, Kuopio Univ Hosp, Inst Clin Med, Dept Med, Yliopistonranta 1 C, Canth Bldg, B wing, FI-70029 Kuopio, Finland
[4] Cent Finland Hlth Care Dist, Dept Med, Jyvaskyla 40620, Finland
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2023年 / 30卷 / 04期
关键词：
APOLIPOPROTEIN-A-I; RISK-FACTORS; CHOLESTEROL; HDL; MORTALITY; LIPIDS;
D O I：
10.1093/eurjpc/zwac272
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women', by C.C. Faaborg-Andersen et al. https://doi.org/ 10.1093/eurjpc/zwac263.
引用
收藏
页码：290 / 292
页数：3
相关论文
共 50 条
  • [1] ASSOCIATION BETWEEN HIGH-DENSITY LIPOPROTEIN AND CARDIOVASCULAR DISEASE OUTCOMES
    Sidhu, M. S.
    Pragani, M.
    Boden, W. E.
    Smith, R. P.
    Bopp, L. H.
    Rafferty, M. E.
    CARDIOLOGY, 2016, 134 : 302 - 302
  • [2] Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations
    Liu, Chang
    Dhindsa, Devinder
    Almuwaqqat, Zakaria
    Ko, Yi-An
    Mehta, Anurag
    Alkhoder, Ayman A.
    Alras, Zahran
    Desai, Shivang Rajan
    Patel, Krishan Jignesh
    Hooda, Ananya
    Wehbe, Mohamad
    Sperling, Laurence S.
    Sun, Yan, V
    Quyyumi, Arshed A.
    JAMA CARDIOLOGY, 2022, 7 (07) : 672 - 680
  • [3] High-density lipoprotein subclasses and their relationship to cardiovascular disease
    Superko, H. Robert
    Pendyala, Lakshmana
    Williams, Paul T.
    Momary, Katherine M.
    King, Spencer B., III
    Garrett, Brenda C.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (06) : 496 - 523
  • [4] Emerging role of high-density lipoprotein in the prevention of cardiovascular disease
    Brousseau, ME
    DRUG DISCOVERY TODAY, 2005, 10 (16) : 1095 - 1101
  • [5] High-density lipoprotein therapeutics and cardiovascular prevention
    Fazio, Sergio
    Linton, MacRae F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 411 - 419
  • [6] Raising high-density lipoprotein cholesterol for better prevention of cardiovascular disease
    Birjmohun, Rakesh S.
    Stroes, Erik S. G.
    Kastelein, John J. P.
    FUTURE LIPIDOLOGY, 2006, 1 (01): : 47 - 54
  • [7] Adipose Modulation of High-Density Lipoprotein Cholesterol Implications for Obesity, High-Density Lipoprotein Metabolism, and Cardiovascular Disease
    McGillicuddy, Fiona C.
    Reilly, Muredach P.
    Rader, Daniel J.
    CIRCULATION, 2011, 124 (15) : 1602 - 1605
  • [8] High-density lipoprotein and inflammation in cardiovascular disease
    Connelly, Margery A.
    Shalaurova, Irina
    Otvos, James D.
    TRANSLATIONAL RESEARCH, 2016, 173 : 7 - 18
  • [9] High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
    Calabresi, Laura
    Gomaraschi, Monica
    Franceschini, Guido
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (13) : 1494 - 1503
  • [10] Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels
    Hausenloy, Derek J.
    Yellon, Derek M.
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (05) : 473 - 482
12345